4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-042544
Chief Commercial Officer sold 11,127 shares at $0.58 ($6,506)
- Chief Commercial Officer acquired 34,946 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baldry Mark Chief Commercial Officer | 2024-10-04 | Grant or award | +34,946 | 59,636 | D | ||
| Baldry Mark Chief Commercial Officer | 2024-10-07 | Sale | −11,127 | $0.58 | $6,506 | 48,509 | D |
| Open-market sales · 11,127 sh · avg $0.58 · $6,506 | |||||||
Loading xslF345X05/wk-form4_1728420266.xml…